Health
Modified SARS-CoV-2 receptor-binding domain could increase vaccine efficacy, says study – News-Medical.Net
A team of researchers from the USA and China have engineered a receptor-binding domain (RBD) that they claim improves the immunogenicity of multivalent SARS-CoV-2…
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen responsible for the coronavirus disease 2019 (COVID-19) pandemic, has spread to over 58.8 million worldwide and caused over 1.3 million deaths. The rush to develop safe and effective vaccines to prevent the ongoing spread of SARS-CoV-2 is nearing the finish line as several promising candidates await regulatory body approval for widescale distribution and use.
A team of researchers from the USA and China have engineered a…
-
General11 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General22 hours agoBritish and US planes fly 12-hour mission to patrol Russian border
-
Noosa News16 hours agoFatal traffic crash, Baringa – Sunshine Coast
-
General12 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery